We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessment of Price and Clinical Benefit of Cancer Drugs in Canada, 2011-2020.
- Authors
Jenei, Kristina; Meyers, Daniel; Gyawali, Bishal
- Abstract
This cohort study examines the association between approval characteristics, clinical benefit, and prices of cancer drugs recommended for reimbursement by the Canadian Agency for Drug and Technology in Health.
- Subjects
CANADA; THERAPEUTIC use of antineoplastic agents; DRUG approval; KRUSKAL-Wallis Test; NONPROFIT organizations; IMMUNE checkpoint inhibitors; RETROSPECTIVE studies; MANN Whitney U Test; REGRESSION analysis; ECONOMICS; HEALTH insurance reimbursement; PHARMACEUTICAL industry; TUMORS; PROGRESSION-free survival; LONGITUDINAL method; OVERALL survival
- Publication
JAMA Network Open, 2023, Vol 6, Issue 1, pe2253438
- ISSN
2574-3805
- Publication type
Article
- DOI
10.1001/jamanetworkopen.2022.53438